IL144892A0 - Therapeutic agent for intermittent claudication - Google Patents

Therapeutic agent for intermittent claudication

Info

Publication number
IL144892A0
IL144892A0 IL14489200A IL14489200A IL144892A0 IL 144892 A0 IL144892 A0 IL 144892A0 IL 14489200 A IL14489200 A IL 14489200A IL 14489200 A IL14489200 A IL 14489200A IL 144892 A0 IL144892 A0 IL 144892A0
Authority
IL
Israel
Prior art keywords
therapeutic agent
intermittent claudication
claudication
intermittent
therapeutic
Prior art date
Application number
IL14489200A
Other languages
English (en)
Original Assignee
Ajinomoto Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Kk filed Critical Ajinomoto Kk
Publication of IL144892A0 publication Critical patent/IL144892A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL14489200A 1999-02-26 2000-02-24 Therapeutic agent for intermittent claudication IL144892A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11050150A JP2000247882A (ja) 1999-02-26 1999-02-26 間歇性跛行治療薬
PCT/JP2000/001046 WO2000051604A1 (fr) 1999-02-26 2000-02-24 Remedes contre la claudication intermittente

Publications (1)

Publication Number Publication Date
IL144892A0 true IL144892A0 (en) 2002-06-30

Family

ID=12851167

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14489200A IL144892A0 (en) 1999-02-26 2000-02-24 Therapeutic agent for intermittent claudication

Country Status (19)

Country Link
US (1) US6476049B2 (pt)
EP (1) EP1155693A4 (pt)
JP (1) JP2000247882A (pt)
KR (1) KR20010102388A (pt)
CN (1) CN1407892A (pt)
AU (1) AU2690700A (pt)
BG (1) BG105826A (pt)
BR (1) BR0008543A (pt)
CA (1) CA2373463A1 (pt)
CZ (1) CZ20013048A3 (pt)
HU (1) HUP0200113A3 (pt)
IL (1) IL144892A0 (pt)
MX (1) MXPA01008669A (pt)
NO (1) NO20014125L (pt)
NZ (1) NZ513687A (pt)
SK (1) SK12132001A3 (pt)
WO (1) WO2000051604A1 (pt)
YU (1) YU62101A (pt)
ZA (1) ZA200106782B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000247882A (ja) 1999-02-26 2000-09-12 Ajinomoto Co Inc 間歇性跛行治療薬
EP1430890A4 (en) * 2001-09-26 2007-01-17 Mitsubishi Pharma Corp THROMBUS / THROMBOGENESIS INHIBITORS
CN114796182B (zh) * 2021-01-27 2023-12-12 中国海洋大学 益母草碱在用于制备防治间歇性跛行的药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100351012B1 (ko) * 1994-04-20 2002-12-26 아지노모토 가부시키가이샤 피페리딘유도체및이를함유하는항혈소판제
JP2962186B2 (ja) * 1994-04-20 1999-10-12 味の素株式会社 ピペリジン誘導体及びそれを含有するセロトニン拮抗薬
AU6230398A (en) * 1997-02-27 1998-09-18 Ajinomoto Co., Inc. Thrombolytic agent
JP2000247882A (ja) 1999-02-26 2000-09-12 Ajinomoto Co Inc 間歇性跛行治療薬

Also Published As

Publication number Publication date
HUP0200113A2 (en) 2002-06-29
EP1155693A4 (en) 2006-12-27
SK12132001A3 (sk) 2001-12-03
EP1155693A1 (en) 2001-11-21
ZA200106782B (en) 2002-08-16
HUP0200113A3 (en) 2002-12-28
YU62101A (sh) 2004-07-15
MXPA01008669A (es) 2002-03-14
US20020037906A1 (en) 2002-03-28
NO20014125D0 (no) 2001-08-24
US6476049B2 (en) 2002-11-05
AU2690700A (en) 2000-09-21
BG105826A (en) 2002-04-30
JP2000247882A (ja) 2000-09-12
CA2373463A1 (en) 2000-09-08
NZ513687A (en) 2001-09-28
NO20014125L (no) 2001-08-24
WO2000051604A1 (fr) 2000-09-08
CN1407892A (zh) 2003-04-02
BR0008543A (pt) 2001-11-06
CZ20013048A3 (cs) 2002-01-16
KR20010102388A (ko) 2001-11-15

Similar Documents

Publication Publication Date Title
GB9911863D0 (en) Therapeutic agents
GB9905010D0 (en) Therapeutic agents
IL150030A0 (en) Therapeutic agents
GB9904786D0 (en) Therapeutic agents
GB9929685D0 (en) Therapeutic agents
GB9929687D0 (en) Therapeutic agents
GB9930570D0 (en) Therapy
GB9921351D0 (en) Therapeutic agents
GB9911881D0 (en) Therapeutic agents
GB9907243D0 (en) Therapy
PL339848A1 (en) Therapeutic agent against hypephosphataemia
HK1047241A1 (zh) 放射線防護劑
GB9903476D0 (en) Therapeutic agents
GB9929569D0 (en) Therapeutic agents
GB9914744D0 (en) Therapeutic agents
GB9900222D0 (en) Therapeutic compounds
GB9903119D0 (en) Therapeutic agents
GB0030067D0 (en) Therapeutic agent
IL144892A0 (en) Therapeutic agent for intermittent claudication
IL147078A0 (en) Therapeutic agents
GB9914745D0 (en) Therapeutic agents
GB9902881D0 (en) Therapeutic agents
HK1041659A1 (zh) 癌治療藥劑供給裝置
HUP0105469A3 (en) Therapeutic drugs comprising pyrroloazepines for treating intermittent claudication
GB9914743D0 (en) Therapeutic agents